Sumitomo Mitsui Trust Group, Inc., a registered investment adviser, initiated a new position in Merck & Co., Inc. (NYSE:MRK) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 6,971,801 shares of the Healthcare company, valued at approximately $733.9M as of the filing date.
Merck & Co., Inc.'s stock currently trades at $108.23 with a market capitalization of $248.8B.
